Acute Respiratory Barrier Disruption by Ozone Exposure in Mice by Sokolowska, Milena et al.
Zurich Open Repository and
Archive
University of Zurich
Main Library
Strickhofstrasse 39
CH-8057 Zurich
www.zora.uzh.ch
Year: 2019
Acute Respiratory Barrier Disruption by Ozone Exposure in Mice
Sokolowska, Milena ; Quesniaux, Valerie F J ; Akdis, Cezmi A ; Chung, Kian Fan ; Ryffel, Bernhard ;
Togbe, Dieudonnée
Abstract: Ozone exposure causes irritation, airway hyperreactivity (AHR), inflammation of the airways,
and destruction of alveoli (emphysema), the gas exchange area of the lung in human and mice. This
review focuses on the acute disruption of the respiratory epithelial barrier in mice. A single high dose
ozone exposure (1 ppm for 1 h) causes first a break of the bronchiolar epithelium within 2 h with leak
of serum proteins in the broncho-alveolar space, disruption of epithelial tight junctions and cell death,
which is followed at 6 h by ROS activation, AHR, myeloid cell recruitment, and remodeling. High ROS
levels activate a novel PGAM5 phosphatase dependent cell-death pathway, called oxeiptosis. Bronchiolar
cell wall damage and inflammation upon a single ozone exposure are reversible. However, chronic ozone
exposure leads to progressive and irreversible loss of alveolar epithelial cells and alveoli with reduced gas
exchange space known as emphysema. It is further associated with chronic inflammation and fibrosis
of the lung, resembling other environmental pollutants and cigarette smoke in pathogenesis of asthma,
and chronic obstructive pulmonary disease (COPD). Here, we review recent data on the mechanisms of
ozone induced injury on the different cell types and pathways with a focus on the role of the IL-1 family
cytokines and the related IL-33. The relation of chronic ozone exposure induced lung disease with asthma
and COPD and the fact that ozone exacerbates asthma and COPD is emphasized.
DOI: https://doi.org/10.3389/fimmu.2019.02169
Posted at the Zurich Open Repository and Archive, University of Zurich
ZORA URL: https://doi.org/10.5167/uzh-180548
Journal Article
Published Version
 
 
The following work is licensed under a Creative Commons: Attribution 4.0 International (CC BY 4.0)
License.
Originally published at:
Sokolowska, Milena; Quesniaux, Valerie F J; Akdis, Cezmi A; Chung, Kian Fan; Ryffel, Bernhard;
Togbe, Dieudonnée (2019). Acute Respiratory Barrier Disruption by Ozone Exposure in Mice. Frontiers
in Immunology, 10:2169.
DOI: https://doi.org/10.3389/fimmu.2019.02169
REVIEW
published: 13 September 2019
doi: 10.3389/fimmu.2019.02169
Frontiers in Immunology | www.frontiersin.org 1 September 2019 | Volume 10 | Article 2169
Edited by:
Rudolf Lucas,
Augusta University, United States
Reviewed by:
Juerg Hamacher,
Lindenhofspital, Switzerland
Dong Li,
Jilin University, China
*Correspondence:
Bernhard Ryffel
bryffel@cnrs-orleans.fr
Dieudonnée Togbe
dtogbe@cnrs-orleans.fr
Specialty section:
This article was submitted to
Inflammation,
a section of the journal
Frontiers in Immunology
Received: 10 May 2019
Accepted: 28 August 2019
Published: 13 September 2019
Citation:
Sokolowska M, Quesniaux VFJ,
Akdis CA, Chung KF, Ryffel B and
Togbe D (2019) Acute Respiratory
Barrier Disruption by Ozone Exposure
in Mice. Front. Immunol. 10:2169.
doi: 10.3389/fimmu.2019.02169
Acute Respiratory Barrier Disruption
by Ozone Exposure in Mice
Milena Sokolowska 1,2, Valerie F. J. Quesniaux 3, Cezmi A. Akdis 1,2, Kian Fan Chung 4,
Bernhard Ryffel 3* and Dieudonnée Togbe 3,5*
1 Swiss Institute of Allergy and Asthma Research, University of Zurich, Davos, Switzerland, 2Christine Kühne – Center for
Allergy Research and Education (CK-CARE), Davos, Switzerland, 3 Laboratory of Experimental and Molecular Immunology
and Neurogenetics (INEM), UMR 7355 CNRS-University of Orleans, Orléans, France, 4 Airways Disease, National Heart and
Lung Institute, Imperial College London, London, United Kingdom, 5 ArtImmune SAS, Artinem, Orléans, France
Ozone exposure causes irritation, airway hyperreactivity (AHR), inflammation of the
airways, and destruction of alveoli (emphysema), the gas exchange area of the lung
in human and mice. This review focuses on the acute disruption of the respiratory
epithelial barrier in mice. A single high dose ozone exposure (1 ppm for 1 h) causes
first a break of the bronchiolar epithelium within 2 h with leak of serum proteins in the
broncho-alveolar space, disruption of epithelial tight junctions and cell death, which is
followed at 6 h by ROS activation, AHR, myeloid cell recruitment, and remodeling. High
ROS levels activate a novel PGAM5 phosphatase dependent cell-death pathway, called
oxeiptosis. Bronchiolar cell wall damage and inflammation upon a single ozone exposure
are reversible. However, chronic ozone exposure leads to progressive and irreversible
loss of alveolar epithelial cells and alveoli with reduced gas exchange space known
as emphysema. It is further associated with chronic inflammation and fibrosis of the
lung, resembling other environmental pollutants and cigarette smoke in pathogenesis
of asthma, and chronic obstructive pulmonary disease (COPD). Here, we review recent
data on the mechanisms of ozone induced injury on the different cell types and pathways
with a focus on the role of the IL-1 family cytokines and the related IL-33. The relation of
chronic ozone exposure induced lung disease with asthma and COPD and the fact that
ozone exacerbates asthma and COPD is emphasized.
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INTRODUCTION
Human ozone (O3) exposure represents a major health issue (1, 2) playing an important role in the
pathogenesis of chronic respiratory diseases such as asthma and chronic obstructive pulmonary
disease (COPD). Ozone causes acute epithelial airway wall injury, inflammation, and airway
hyperreactivity (AHR). Ozone elicits irritation of the airways with cough, bronchoconstriction, and
inflammatory cell infiltration with loss of respiratory function. AHR represents a complex response
of the airways to the release of bronchoconstrictive mediators and cholinergic stimulation, and is
a hallmark of ozone exposure which is shared with allergic asthma. Furthermore, increased ozone
exposure, especially occurring during thunderstorms, provokes severe exacerbations of asthma and
may even contribute to the asthma-related deaths (3–7). A recent epidemiologic study revealed
that even a short-term exposure to ambient air pollution such as PM2.5, O3, and NO2 significantly
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increased the risk of asthma mortality (8). Chronic ozone
exposure leads to a progressive loss of the gas exchanging alveoli,
a phenomenon known as emphysema, usually associated with
chronic inflammation, fibrosis, and terminal respiratory failure,
observed in patients with chronic obstructive pulmonary disease
(COPD) and severe asthma (9). Of note, the pathogenesis of
chronic lung diseases is complex and comprises the effects
of various environmental particulates, toxins, chemical sand
pollutants, detergents, respiratory viruses, microbial dysbiosis as
well as allergen exposure, and is influenced by diverse genetic and
epigenetic factors (10–15).
The respiratory airway epithelium forms a physical barrier
and first line of defense of mucosal immunity (16, 17). Tight
junctions (TJ) and adherens junctions (AJ), fluid, mucus,
surfactant proteins, and motility of cilia are critical for the barrier
control and innate response (18). Ozone impairs the function
of critical proteins of the epithelial barrier (19), which will be
discussed later. In addition, there is increased proliferation of
the airway epithelial cells following exposure to ozone, likely as
a result of direct oxidative epithelial damage (20).
Inflammatory cytokines such as members of the IL-1 family,
including IL-1α, IL-1β, IL-18, IL-33, and IL-36 (21–23) as
well others and several chemokines are upregulated upon
ozone exposure and play major roles in the inflammatory
and pathogenic response. IL-1 is involved in the inflammatory
response (24), while IL-33 may have protective effects in ozone-
induced inflammation as discussed below. We review here the
most recent findings on ozone involvement in bronchiolar
epithelial barrier dysfunction, acute lung injury, inflammation,
resolution, and defective repair (20).
RESPIRATORY BARRIER INTEGRITY
The integrity of the epithelial barrier depends on tight junctions
(TJ) and adherens junctions (AJ), which insure apicobasal cell
polarity, but also mucus, fluid, and function of the cilia (18, 25–
27). Tight junctions comprise the claudin family, occluding,
and tricellulin. In addition, several scaffolding proteins, such
as zonulae occludens (ZO)-1, ZO-2, ZO-3, multi-PDZ domain
protein 1, and others have been identified in the tight junctions
(28, 29). E-cadherin, as well as TJs were reduced in patients with
asthma (30–32). Common respiratory viruses, such as human
rhinovirus (HRV) (33, 34) or respiratory syncytial virus (RSV)
(35) disrupt and impair airway epithelial barrier and delay
healing of infected epithelium (36), through NADPH oxidase-1
Abbreviations: AHR, airways hyperreactivity; AIFM1, mitochondrial apoptosis
inducing factor 1; AJ, adherens junctions; AREG, amphiregulin; BAL, broncho
alveolar lavage to quantify cell counts; BALF, broncho alveolar lavage fluid to detect
protein levels; GR1, Ly-6G antibody depleting neutrophils; IL-33, interleukin-
33; IL-33R/ST2, interleukin-33 receptor/ suppression of tumorigenicity 2;
CXCL1/KC, keratinocyte chemoattractant; COPD, chronic obstructive pulmonary
disease; LCN-2, lipocalin 2; CCL1/MCP-1, chemokine ligand 2; CCL2/MIP-2,
chemokine (C-X-C motif) ligand 2; MMP-9, matrix metalloproteinase 9; MPO,
myeloperoxidase; PGAM5, mitochondrial serine/threonine-protein phosphatase;
rmIL-33, recombinant mouse IL-33; ROS, reactive oxygen species; RNS, reactive
nitrogen species; TIMP-1, tissue inhibitor metalloproteinase 1; TJ, tight junctions;
WT, wild type mice.
and ROS-dependent mechanisms (33, 37, 38). Disruption of tight
junctions with leak of the epithelium allows systemic access of
irritants, pathogen, and allergens (15, 39), as well as the drainage
of host proteins, lipid mediators, or cells into the airway lumen,
where they may perpetuate inflammatory response, acting back
on epithelium. Depending on the dose of allergen and airway
inflammation, the Zo-1 and Cld-18 proteins expression are
decreased in eosinophilic asthma, but it is evenmore pronounced
in mixed and neutrophilic asthma phenotype (27). Epithelial
barrier is impaired not only in the lower airways of patients
with asthma (32), but also in the nasal mucosa of allergic rhinitis
due to house dust mite (HDM) (40) displaying reduced occludin
and ZO-1 levels. Ozone exposure disrupts tight junction proteins
and hence the function of the respiratory barrier as reported
recently (27, 41, 42).
DIRECT DISRUPTION OF EPITHELIAL
BARRIER BY OZONE
Ozone causes immediate damage of the bronchiolar epithelial
cell barrier with cell stress, desquamation, and death with leak
of protein and DNA into the airspace within 1–2 h. Since several
mediators of inflammation are not yet detectable at this time, we
postulate that ozone induced ROS has a direct effect on essential
components of the bronchiolar cell integrity with reduced
cilia function, tight junctions, mucus, and surfactant protein
production (43). This first phase of ozone induced damage of the
airway epithelium is followed by a second phase at of bronchiolar
epithelial injury and cell death with protein leak and influx
of neutrophils, ROS expressing myeloid cells, IL-1α and IL-33
production by epithelial and myeloid cells. Thus, the data suggest
that ozone causes a biphasic response, an immediate direct injury
via ROS and a second damage by myeloid cells, moving to and
exacerbating epithelial cell damage. Indeed, neutrophil depletion
by antibody against granulocytes attenuates the second phase.
Similar disruptions of the respiratory barrier as shown for ozone
has been described before by other air pollutants such nitrogen
dioxide, disulfide, particle, chemicals, and cigarette smoke- all of
which can cause chronic pulmonary diseases, but usually require
longer exposure time and at higher concentrations than ozone
(38, 44). A schematic view of the initial events at the respiratory
barrier and early repair process is given in Figure 1.
DISRUPTION OF TIGHT JUNCTIONS
Upon a single ozone exposure, we found enhanced expression
of E-cadherin, ZO-1, and claudin-4 using immunofluorescence
(43). By contrast, the epithelial E-cadherin, ZO-1, and Cld-4
expression are reduced in the absence of IL-33 (43). Epithelial
E-cadherin expression is also reduced in IL-33/ST2 receptor
deficient mice, suggesting a protective effect of IL-33. At the
transcriptional level, an increased Cld-4 level (4–6 h) or E-
cadherin (4–8 h) expression were found. Therefore, the data
suggest that IL-33/ST2 signaling has a protective effect. This
IL-33-dependant epithelial protection is probably an early
defense mechanism in physiological condition. However, in
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FIGURE 1 | Ozone-induced epithelial barrier dysfunction, AHR, ROS production, cell recruitment, cell desquamation, remodeling, and repair in mice. (A) Scheme
showing ozone/ROS-induced disruption of bronchiolar epithelium, cell integrity, tight junctions with protein leak, and cell death with the release of IL-33. Neutrophils
and macrophages are recruited within 18 h and macrophages release protective amphiregulin (AREG) with resolution of inflammation and remodeling (43).
(B) Micrograph of ozone-induced disruption of bronchiolar epithelium with desquamation, cell death, and focal inflammation at 18 h after exposure (1 h, 1 ppm), scale
bar 100µm. (C) Airways hyperreactivity (AHR): ozone enhances methacholine induced bronchoconstriction measured as resistance (RL) using invasive
plethysmography 24 h after exposure (1 h, 1 ppm, unpublished data).
the settings of allergic inflammation, excess of pathogenic
Th2 cells and ILC2 in the epithelial wall, reacting to IL-
33, lead to increased inflammation, and symptoms of the
disease. Interestingly, in the chronic airway inflammation
impairment of the barrier consists of decreased expression
of several TJ proteins, but also a subsequent increase of
TJs, such as CLD-4 (27). Recent reports confirm that ozone
exposure impairs the function of epithelial barrier tight junction
proteins (27, 41, 42).
Within 24 h after ozone exposure basal cells proliferate
and at 48 h the bronchiolar epithelium is restored with firm
tight junctions, mucus, and cilia (43). The mechanisms of
inflammation including resolution of inflammation, remodeling
of airways, and repair mechanisms are an area of intense
research (13, 37, 45–47).
AIRWAY HYPERREACTIVITY
Ozone exposure causes bronchoconstriction measured by the
pulmonary function tests in humans and airway hyperreactivity
(AHR) in rodents and humans as assessed by increased
reactivity of the airways to cholinergic stimulation (44, 48). Mice
exposed to ozone display a dose-dependent increased of airway
resistance (RL) to methacholine aerosol as measured by invasive
plethysmograph (Figure 1C). This has also been demonstrated in
humans (48).
The underlying mechanisms of AHR are due to the complex
response of the airway wall including effect of oxidative stress
(49, 50) activation of kinase pathways, the release of chemokines,
cytokines (51, 52), and lipid mediators, increased sensitivity of
bronchial smooth muscle cells either directly or through an effect
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on innervation and neuropeptides (53), which is beyond the
scope of this review.
The transient receptor potential cation channel subfamily V
member1 (TRPV1) is upregulated by ozone in experimental
asthma, which is sensitive to a TRPV1 antagonist. The
TRPV1 antagonist suppresses the neuropeptide calcitonin gene-
related peptide (CGRP) and thymic stromal lymphopoietin
(TSLP) (54). Thus, TRPV1 expression may be an important
mechanism for asthma exacerbation upon exposure to ozone
and other environmental pollutants. Ozone induced AHR and
lung inflammation is characterized by increased neutrophils
recruitment in the airways and lung (54), although the
role of neutrophils in inducing AHR is controversial (55,
56). Interestingly, NKT cell-deficient (CD1d−/− and Jα18−/−)
mice are resistant to ozone-induced AHR and have reduced
neutrophils. Further, anti-CD1d antibody blockade of NKT cell
activation prevented ozone-induced AHR. NKT cells producing
IL-17 causes AHR, which was prevented in IL-17A deficient
mice or by anti-IL-17 antibody blockade (57, 58). ROS mediated
AHR and inflammation further depends on danger activated
proteins such as HMGB1, HSPs, RAGE, and others activating
the molecular pattern recognition receptors Toll-Like Receptors
(TLR) 2 and 4 and the adaptor protein, MyD88 (59). However,
the list of endogenous mediators activating AHR includes lipid
mediators, prostaglandins and leukotrienes in response to ozone
is incomplete (51, 60, 61).
These effects of ozone on bronchoconstriction and AHR
raise the possibility that ozone may be involved in underlying a
specific type of asthma, namely the neutrophilic inflammatory
phenotype of asthma (62, 63). However, the evidence linking
neutrophilic asthma to exposure to ozone as a constituent of
pollution is unclear, although an increase in exacerbations of
asthma in patients with asthma following a peak increase in levels
of environmental ozone has been reported (64).
REACTIVE OXYGEN SPECIES AND CELL
DEATH VIA OXEIPTOSIS
Ozone generates reactive oxygen species (ROS), mitochondrial
damage with oxidant stress activating the NLRP3 inflammasome
and contributes to AHR, airflow obstruction, and emphysema
(2, 65). ROS has a dual effect on cell integrity: at low
concentration, it has a beneficial, cytoprotective effect, while at
high concentration it is cytotoxic causing cell death. KEAP1
acts as a ROS sensor, which triggers at high ROS levels as
found upon ozone exposure a novel caspase-independent cell-
death pathway known as oxeiptosis (66, 67) (Figure 2). We
found that ROS-induced cell-death depends on interactions
of cellular ROS sensor KEAP1 and the phosphatase PGAM5
with antioxidant function and AIFM1, a pro-apoptotic factor.
At high ROS concentration PGAM5 is released from the
complex and activates the pro-apoptotic factor AIFM1 inducing
apoptotic pathway. PGAM5 deficient mice have enhanced lung
inflammation with proinflammatory cytokines upon ozone-
exposure. Furthermore, in Influenza A virus infection, viral
load and lung inflammation were increased in PGAM5 deficient
mice, which succumbed to infection (68, 69). Oxeiptosis
represents a different, non-canonical cell-death pathway, which
is novel, ROS-sensitive, caspase independent, cell-death pathway
important for protection against inflammation induced by
ROS or viral pathogens (69). The molecular events of
oxeiptosis are depicted in Figure 2. Other cell-death pathways
include inflammasome-mediated apoptosis and pyroptosis,
but also necroptosis and ferroptosis. Their relative roles
of these pathways need to be further investigated in the
ozone model.
INFLAMMATORY CELLS RECRUITED IN
THE LUNG
Cell and tissue damage induce inflammatory cell recruitment
including neutrophils, macrophages, innate lymphoid cells, and
more. Neutrophils play a critical role in acute and chronic
inflammation (70). Neutrophils migrate within and through
the vessels depending polarization within activated venules
activate platelets present in the bloodstream (71). Neutrophils
scan for activated platelets resulting in the redistribution of
receptors via the selectin ligand PSGL-1 that drive neutrophil
migration allowing the interaction with the endothelium and
the circulation before inflammation proceeds. Thus, a close
interaction between neutrophils and platelets drives neutrophil
migration to sites of injury or cell death. We have described
the inflammatory response upon ozone exposure (24). Upon a
single ozone exposure at 1 ppm for 1 h the analysis at 4 h after
ozone exposure revealed desquamation of epithelial cells with
increased CXCL1, CCL2/MIP-2, and IL-6 production, which was
followed by increased macrophages and neutrophils in BALF at
6 h. At 24 h, the inflammatory response was further enhanced in
the absence of ST2 or IL-33 with predominant neutrophils and
interstitial macrophages in the lung. We investigated the role in
the second inflammatory phase by GR-1 antibody depletion of
neutrophils and other myeloid cells. GR-1 cell depletion with
anti-GR1 antibody reduced protein leak, myeloid and epithelial
cell in BALF and reduced parenchymal injury and inflammation
with reduced MMP9 and increased amphiregulin expression
as sign of tissue repair. Therefore, neutrophils contribute to
tissue injury and repair as reported in other inflammatory
models (72).
Besides T lymphocytes not discussed here, innate lymphocytes
(ILC) are involved in the early immune response (54, 73,
74). Tissue-resident ILC-2 is involved in both physiologic and
pathologic responses, yet their physical tissue niches are poorly
described (75). ILC2 are recruited upon ozone exposure, but
there is little information available on their roles in inflammation
and airway hyperreactivity (6, 43, 76, 77).
Natural killer T cells expressing IL-17 may induce airway
hyperreactivity, which depended on IL-17 expression as
mentioned before (57). Platelets are likely involved in
ozone induced neutrophilic inflammation, but no studies
address their role in ozone induced tissues injury. The
role of platelets has been recently studied in allergic
inflammation (78).
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FIGURE 2 | High ROS levels induce oxeiptosis, a novel cell death via the phosphatase PGAM5 activating the death effector AIFM1 in mice. While low concentration of
ROS (0.1mM) release the cytoprotective NRF2 from the KEAP1/PGAM5 complex in the cytosol, at high concentration of ROS (1mM), the phosphatase PGAM5 is
released from the mitochondrial KEAP1/NRF2/PGAM5 complex and PGAM5 dephosphorylates AIFM1, which is the effector protein defining the oxeiptosis death
pathway (68).
Fibroblast, stromal cells, pericytes, and endothelial cells are
potential targets of ozone (79, 80), which is an area for further
investigations. A recent study defined a perivascular fibroblast-
like stromal cells producing IL-33 and TSLPwhich regulate ILC2s
and type 2 immunity (75).
Two major previous morphological investigations on the
effects of a 4 h exposure to 3 ppm ozone on rat lungs are
worth mentioning (81, 82). The epithelial damage was located
centrally showing cell death of bronchiolar epithelium and
alveolar pneumonocytes. Lesions in capillary endothelium with
endothelial swelling were widespread with ring-like formations
of endothelial membranes peripherally with alveolar and
interstitial edema. These results show that ozone damage is
in the centro-acinar regions and affects both endothelial and
epithelial cells.
INTERLEUKINS WITH INFLAMMATORY OR
PROTECTIVE ROLES
Upon ozone exposure, several interleukins (IL) are increased
and may regulate inflammation. Here we focus on two IL-
1 family members, IL-1a and IL-33 (23, 83–85), which are
known as alarmins, released upon cell stress and death. An
overview of IL1 members and IL-33 and their receptors is shown
in Figure 3.
INTERLEUKIN-1 ENHANCING
INFLAMMATION
A role of interleukin-1 (IL-1)-associated cytokines has been
reviewed recently (24). We investigated inflammation after a
single ozone exposure (1 ppm for 1 h) using IL-1α-, IL-1β-
, and IL-18-deficient mice or neutralizing anti-IL-1α antibody
to investigate their role in epithelial cell death. IL-1α was
increased within 1 h after ozone exposure. Epithelial injury,
inflammation and AHR were IL-1α-dependent. Further, we
found that IL-1α signaling via IL-1R1/MyD88 was type I
alveolar epithelial cell dependent as demonstrated by cell specific
MyD88 deletion in mice (86). By contrast, inflammation and
epithelial injury were less reduced in absence of IL-1β and
IL-18. In conclusion, the IL-1α induced tissue damage and
inflammation is mediated by IL-1R/MyD88 signaling in epithelial
cells. Interestingly, in more chronic disease settings, IL-1β is
increased in the lungs of mice with neutrophilic phenotype
of asthma and in patients with neutrophilic asthma (27).
Additionally, in humans IL-1β may lead to impairment of
epithelial barrier function and increase of mucus production
(27). Therefore, IL-1α or IL-1 receptor may represent a
therapeutic target to attenuate ozone-induced lung inflammation
and airway hyperreactivity. The use of neutralizing IL-1β
antibody and IL1-RA antagonist is in fact used for different
experimental conditions.
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FIGURE 3 | Comparison of IL-1 and IL-33 and their membrane receptors in mice. Scheme of IL-1 (A) and IL-33 (B), showing the different ligands and receptors.
(A) IL-1αβ binds to IL-1R1 and induces a conformational change in the extracellular domain of IL-1R1, enabling its interaction with IL-1RAcP, which is required for
intracellular signaling, including MyD88-dependent activation. IL-1Ra competes with IL-1αβ for the binding to IL-1R1; the binding of IL-1Ra to IL-1R1 prevents IL-1αβ
binding, the recruitment of IL-1RAcP and the activation of intracellular signaling pathways. IL-1R2 acts as a decoy receptor on the cell surface to IL-1RAcP.
(B) Interleukin−33 (IL−33) binds to its transmembrane receptor suppression of tumorigenicity 2 (ST2) and induces a conformational change that allows ST2 to
interact with IL−1 receptor accessory protein (IL−1RAcP). Activation of ST2 and IL−1RAcP leads to the Toll/IL−1 receptor (TIR) domains clustering and the
recruitment of signaling adaptor myeloid differentiation primary response protein 88 (MYD88) (23).
INTERLEUKIN-33 ATTENUATING
INFLAMMATION
IL-33 is another alarmin released rapidly upon ozone and may
have a protective role. IL-33 has homeostatic functions and is
involved in injury and repair. The alarmin IL-33 is expressed at
steady state in tissue cells and released upon airway epithelial
injury and repair during inflammatory process (87, 88). IL-33 has
functions in both innate and adaptive immune response (85). IL-
33 binds to ST2 chain known as IL-33R or IL-1RL1 (89) which
associates with IL-1RAcP (23). The full length, 35 kDa IL-33 is
cleaved by different proteases and is produced by neutrophils,
macrophages, or mast cells that full length IL-33 to several active
moieties that are about 30-fold more active than the full length
form (84, 90, 91). IL-33 receptor ST2 is was first detected in
high endothelial venules in lymphoid tissues in mice (92), but
is found in most innate immune cells including mast cells (85),
innate lymphoid cells (85), myeloid and dendritic cells (93), and
to a lesser extent on Th2 cells (85). Further, nuclear IL-33 may
associate with chromatin in vivo, but the function of nuclear
IL-33 is still unresolved.
IL-33 expression was increased in epithelial and macrophages
and other myeloid cells in mice upon ozone exposure. In
the absence of IL-33 or IL-33R/ST2, epithelial cell injury with
protein leak and myeloid cell recruitment and inflammation
was further increased, while tight junction proteins E-cadherin
and ZO-1, ROS expression in neutrophils, and AHR were
diminished (43). ST2 antibody neutralization recapitulated the
enhanced ozone induced neutrophilic inflammation, while the
administration of rmIL-33 reduced neutrophil recruitment
in IL-33 deficient mice (69). These data demonstrate that
ozone causes an immediate barrier injury, which precedes
myeloid cell mediated inflammatory injury under the control
of the IL-33/ST2 axis. Thus, IL-33/ST2 signaling appears to
be critical for the maintenance of intact epithelial barrier
and inflammation.
SURFACTANT PROTEINS AND MUCUS
Surfactant proteins mucus are the first line protection
protecting the respiratory epithelium. Surfactant protein-D
(SP-D), produced by the airway epithelium, is multimeric
protein sensitive to oxidative stress. SP-D directly inhibits
extracellular DNA trap formation by eosinophils. Allergic
airway sensitization and ozone exposure augmented eosinophilia
and nos2 mRNA (iNOS) activation in the lung tissue with
modification of SP-D in the airways. Thus, the regulatory
feedback between SP-D and eosinophils appears to be destroyed
by the NO-rich oxidative lung tissue environment in asthma
exacerbations (94).
THERAPEUTIC TARGETS
The protective role of antioxidants against ROS/RNS induced
injury and inflammation environmental pollutants has been
reviewed (38, 95). A comprehensive analysis of oxidative stress
in ozone induced lung injury and mitochondrial dysfunction
allowed to identify potential druggable pathways (2, 38, 95,
96). Indeed, several interventions attenuate ozone induced
inflammation such N-acetylcysteine (97), hydrogen disulfide
(98), MIF antagonist (99) as well as blockade of IL-1α (86) or
IL-17A (100), recombinant IL-33 (69), L-arginine promoting
DNA repair (101), Taurine (102). Also, blocking ROS-induced
airway inflammation by apocynin, an NADPH inhibitor has
been targeted in asthma and COPD in human clinical trials
(47, 103). Furthermore, DNA released upon cell death and is
highly inflammatory. In particle-induced lung injury, enzymatic
degradation of DNA by DNase I reduced inflammation (10,
11). The list therapeutic targets are not exhaustive, but new
mechanistic insights may lead to antagonists that are more
efficacious. However, reduction of airborne pollution, especially
high levels of ozone and smog, would be the most efficacious
measure to prevent chronic respiratory disease.
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CONCLUSIONS
Chronic ozone exposure causes chronic lung inflammation,
emphysema, and interstitial fibrosis with progressive loss
of lung function in man and rodents. Furthermore, ozone
enhances the development of chronic lung diseases such as
allergic and non-allergic asthma, COPD, and emphysema.
Recent studies demonstrated the importance of IL-1α, IL-
33, and IL-17A axis in ozone induced lung injury and
inflammation, and a role of PGAM5 emerged, which
defines a novel cell death pathway known as oxeiptosis.
Understanding the fundamental mechanisms of injury and
defective repair likely related to DNA damage, and defining
critical targets require further investigations including clinical
and epidemiological studies. Chronic progressive lung diseases
could be prevented to a great extent by reducing environmental
air pollution, tobacco, and wood fire smoke and smog containing
ozone exposure.
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